Vaccine Confidence During Public Health Challenges and Prior to HPV Vaccine Introduction in Mali
Abstract
:1. Introduction
2. Materials and Methods
2.1. Public Education Intervention on Vaccines
2.2. Healthcare Provider Training
2.3. Data Inputs and Analysis
3. Results
3.1. Public Education Intervention
3.2. Healthcare Provider Training Intervention
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Glossary
COVID | Coronavirus Disease |
SARS-CoV-2 | Severe Acute Respiratory Syndrome Coronavirus 2 |
HIV | Human Immunodeficiency Virus |
TB | Tuberculosis |
HPV | Human Papillomavirus |
HCP | Healthcare provider |
CHW | Community health worker |
References
- World Health Organization. Mali COVID-19. 2023. Available online: https://www.who.int/countries/mli (accessed on 30 March 2025).
- Ly, B.A.; Ahmed, M.A.A.; Millimouno, T.M.; Cissoko, Y.; Faye, C.L.; Traoré, F.B.; Diarra, N.H.; Toure, M.; Telly, N.; Sangho, H.; et al. Information about COVID-19: Lessons learned from Mali. Health Sci. Dis. 2022, 23, 95–100. Available online: https://www.hsd-fmsb.org/index.php/hsd/article/view/4016/3267 (accessed on 11 May 2025).
- Cissoko, M.; Landier, J.; Kouriba, B.; Sangare, A.K.; Katilé, A.; Djimde, A.A.; Berthé, I.; Traore, S.; Thera, I.; Hadiata, M.; et al. SARS-CoV-2 seroprevalence and living conditions in Bamako (Mali): A cross-sectional multistage household survey after the first epidemic wave, 2020. BMJ Open 2020, 13, e067124. [Google Scholar] [CrossRef] [PubMed]
- Maiga, A.I.; Saliou, M.; Kodio, A.; Traore, A.M.; Dabo, G.; Flandre, P.; Fofana, D.B.; Ammour, K.; Tra, N.O.M.E.; Dolo, O.; et al. High SARS-CoV-2 seroprevalence among health care workers in Bamako referral hospitals: A prospective multisite cross-sectional study (ANRS COV11). Clin. Microbiol. Infect. 2022, 28, 900–902. [Google Scholar] [CrossRef] [PubMed]
- Maiga, I.; Cisse, A. COVID-19 Vaccination Programme Kicks off in Mali. 2021. Available online: https://www.unicef.org/mali/en/press-releases/covid-19-vaccination-programme-kicks-mali (accessed on 30 March 2025).
- Crippin, T.; Tounkara, K.; Squibb, E.; Beseme, S.; Barry, K.; Sangare, K.; Coulibaly, S.; Fané, P.; Bagayoko, A.; Koita, O.A.; et al. A story-telling cloth approach to motivating cervical cancer screening in Mali. Front. Public Health 2022, 10, 1051536. [Google Scholar] [CrossRef] [PubMed]
- Crippin, T.; Tounkara, K.; Munir, H.; Squibb, E.; Piotrowski, C.; Koita, O.A.; Teguété, I.; De Groot, A.S. Our Daughters—Ourselves: Evaluating the Impact of Paired Cervical Cancer Screening of Mothers with HPV Vaccination for Daughters to Improve HPV Vaccine Coverage in Bamako, Mali. Vaccines 2024, 12, 1019. [Google Scholar] [CrossRef]
- De Groot, A.S.; Tounkara, K.; Rochas, M.; Beseme, S.; Yekta, S.; Diallo, F.S.; Tracy, J.K.; Teguété, I.; Koita, O.A. Knowledge, attitudes, practices and willingness to vaccinate in preparation for the introduction of HPV vaccines in Bamako, Mali. PLoS ONE 2017, 12, e0171631. [Google Scholar] [CrossRef]
- Teguété, I.; Dolo, A.; Sangare, K.; Sissoko, A.; Rochas, M.; Beseme, S.; Tounkara, K.; Yekta, S.; De Groot, A.S.; Koita, O.A. Prevalence of HPV 16 and 18 and attitudes toward HPV vaccination trials in patients with cervical cancer in Mali. PLoS ONE 2017, 12, e0172661. [Google Scholar] [CrossRef]
- Osuagwu, U.L.; Mashige, K.P.; Ovenseri-Ogbomo, G.; Envuladu, E.A.; Abu, E.K.; Miner, C.A.; Timothy, C.G.; Ekpenyong, B.N.; Langsi, R.; Amiebenomo, O.M.; et al. The impact of information sources on COVID-19 vaccine hesitancy and resistance in sub-Saharan Africa. BMC Public Health 2023, 23, 38. [Google Scholar] [CrossRef]
- Arief, A. Crisis in Mali. Congressional Research Service. 2023. Available online: https://sgp.fas.org/crs/row/IF10116.pdf (accessed on 30 March 2025).
- Njororai, F.; Nyaranga, K.C.; Cholo, W.; Amulla, W.; Ndetan, H. Correlates of COVID-19 Vaccine Acceptance and Hesitancy in Rural Communities in Western Kenya. Vaccines 2023, 11, 1516. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Ozoh, O.B.; Akinkugbe, A.O.; Olukoya, M.A.; Adetifa, I.M.O. Enablers and barriers to COVID-19 vaccine uptake in an urban slum in Lagos, Nigeria: Informing vaccine engagement strategies for the marginalized. Int. Health 2023, 15, 557–565. [Google Scholar] [CrossRef]
- Pengpid, S.; Peltzer, K.; Sathirapanya, C.; Thitichai, P.; Faria de Moura Villela, E.; Rodrigues Zanuzzi, T.; de Andrade Bandeira, F.; Bono, S.A.; Siau, C.S.; Chen, W.S.; et al. Psychosocial factors associated with adherence to COVID-19 preventive measures in low-middle- income countries, December 2020 to February 2021. Int. J. Public Health 2020, 67, 1604398. [Google Scholar] [CrossRef]
- World Bank Group. Mali Featured Indicators. 2020. Available online: https://genderdata.worldbank.org/countries/mali/ (accessed on 30 March 2025).
- Claessens, T.; Eagan, R.L.; Hendrickx, G.; Van Damme, P.; Larson, H.J.; Karafillakis, E. Navigating vaccine confidence: A mixed methods study investigating healthcare providers’ perspectives across four non-EU European regions. Vaccine 2025, 47, 126694. [Google Scholar] [CrossRef] [PubMed]
- Alasmari, A.; Larson, H.J.; Karafillakis, E. A mixed methods study of health care professionals’ attitudes towards vaccination in 15 countries. Vaccine X 2022, 12, 100219. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Arsenault, C.; Ravishankar, S.; Lewis, T.; Armeni, P.; Croke, K.; Doubova, S.V.; McKee, M.; Tarricone, R.; Kruk, M.E. The role of health systems in shaping vaccine decisions: Insights from Italy, Mexico, the United Kingdom, and the United States. Vaccine 2025, 54, 127134. [Google Scholar] [CrossRef] [PubMed]
- Demi, M.J.; Buhl, A.; Huber, B.M.; Burton-Jeangros, C.; Tarr, P.E. Trust, affect, and choice in parents’ vaccination decision-making and health-care provider selection in Switzerland. Sociol. Health Illn. 2022, 44, 41–58. [Google Scholar] [CrossRef]
- Oka, E.; Okada, M.; Ikuno, Y.; Amano, K.; Shioya, S.; Kawabata, M.; Sakurai, R.; Konishi, M.; Nakaya, T.; Katanoda, K.; et al. Area Socioeconomic Status, Vaccination Access, and Female Human Papillomavirus Vaccination. JAMA Netw. Open 2025, 8, 250747. [Google Scholar] [CrossRef] [PubMed]
- Xu, M.A.; Choi, J.; Capasso, A.; DiClemente, R.J. Improving HPV Vaccination Uptake Among Adolescents in Low Resource Settings: Sociocultural and Socioeconomic Barriers and Facilitators. Adolesc. Health Med. Ther. 2024, 15, 73–82. [Google Scholar] [CrossRef]
- Robles, C.; Hernández, M.L.; Almonte, M. Alternative HPV vaccination schedules in Latin America. Salud Publica Mex. 2018, 60, 693–702. (In English) [Google Scholar] [CrossRef]
- Tawat, M. Fake News and COVID-19 Vaccine Hesitancy: A Study of Practices and Sociopolitical Implications in Cameroon. 2021. Available online: https://ssrn.com/abstract=3850603 (accessed on 30 March 2025).
- Brackstone, K.; Atengble, K.; Head, M.; Boateng, L. COVID-19 vaccine hesitancy trends in Ghana: A cross-sectional study exploring the roles of political allegiance, misinformation beliefs, and sociodemographic factors. Pan Afr. Med. J. 2022, 43, 165. [Google Scholar] [CrossRef]
- Hughes, B.; White, K.; West, J.; Criezis, M.; Zhou, C.; Bartholomew, S. Cultural variance in reception and interpretation of social media COVID-19 disinformation in French-Speaking regions. Int. J. Environ. Res. Public Health 2021, 18, 12624. [Google Scholar] [CrossRef]
- Solís Arce, J.S.; Warren, S.S.; Meriggi, N.F.; Scacco, A.; McMurry, N.; Voors, M.; Syunyaev, G.; Malik, A.A.; Aboutajdine, S.; Adeojo, O.; et al. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat. Med. 2021, 27, 1385–1394. [Google Scholar] [CrossRef] [PubMed]
- Diallo, A. Introduction de Vaccin Contre le VPH au Mali: Une Nouvelle Arme Pour Protéger des Générations de Femmes Maliennes. GAVI: Vaccines Work. 2024. Available online: https://www.gavi.org/fr/vaccineswork/introduction-vaccin-contre-vph-mali-nouvelle-arme-proteger-generations-femmes-maliennes (accessed on 30 April 2025).
Have You Heard These Rumors About COVID-19 Vaccines? | |||||
---|---|---|---|---|---|
Vaccine Contains Microchips | Vaccine Contains Magnets | Vaccine Will Change My DNA | Vaccine Will Cause COVID-19 | Vaccine Will Turn Me into a Zombie | |
Never heard | 34% | 35% | 33% | 26% | 37% |
Heard but do not believe | 45% | 47% | 48% | 52% | 49% |
Heard and thinks it is possible | 16% | 15% | 17% | 19% | 12% |
Heard and believe | 4% | 3% | 2% | 3% | 2% |
Prior COVID-19 Testing | Prior COVID-19 Vaccination | Willingness to Be Vaccinated | |
---|---|---|---|
Sex | 1.099 (0.129) | 1.399 (0.158) ** [1.03, 1.91] | 0.882 (0.108) |
Age | 1.004 (0.005) | 1.037 (0.005) *** [1.03, 1.05] | 1.018 (0.005) *** [1.01, 1.03] |
Children | 1.300 (0.172) * | 1.029 (0.135) | 0.864 (0.112) |
Education | 1.245 (0.044) *** [1.14, 1.36] | 1.368 (0.049) *** [1.25, 1.51] | 1.201 (0.044) *** [1.10, 1.31] |
Religiosity | 1.091 (0.052) * [0.99, 1.21] | 1.205 (0.060) *** [1.07, 1.36] | 0.880 (0.041) ** [0.81, 0.95] |
Exposed to HCP Discussion | 1.058 (0.057) | ||
Exposed to Fabric | 1.036 (0.050) | ||
Exposed to Public Education Event | 1.237 (0.065) *** [1.09, 1.41] | ||
Exposed to Poster | 1.015 (0.048) | ||
Exposed to Radio Advertisement | 1.223 (0.059) *** [1.09, 1.37] | ||
Constant | 0.155 (0.037) *** | 0.035 (0.009) *** | 0.382 (0.109) *** |
Number of Observations | 2957 | 3117 | 2427 |
Psuedo R2 | 0.066 | 0.190 | 0.123 |
Trust Community HCPs | Trust Government Health Authorities | |
---|---|---|
Sex | 0.642 (0.161) * [0.47, 0.87] | 1.029 (0.160) |
Age | 1.016 (0.012) | 1.003 (0.006) |
Children | 1.229 (0.341) | 1.205 (0.195) |
Education | 1.413 (0.124) *** [1.11, 1.79] | 1.111 (0.051) ** [1.01, 1.22] |
Religiosity | 0.853 (0.089) * [0.71, 1.03] | 1.027 (0.058) |
Exposed to HCP Discussion | 1.749 (0.183) *** [1.23, 2.49] | 1.293 (0.083) *** [1.10, 1.52] |
Exposed to Fabric | 0.969 (0.108) | 1.280 (0.077) *** [1.10, 1.49] |
Exposed to Public Education Event | 1.514 (0.163) *** [1.10, 2.09] | 1.215 (0.081) *** [1.04, 1.42] |
Exposed to Poster | 0.904 (0.100) | 0.972 (0.056) |
Exposed to Radio Advertisement | 1.478 (0.154) *** [1.09, 2.01] | 1.422 (0.085) *** [1.22, 1.66] |
Constant | 1.064 (0.595) | 0.797 (0.279) |
Number of Observations | 2966 | 2959 |
Psuedo R2 | 0.260 | 0.343 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Crippin, T.; Tounkara, K.; Diarra, I.; Kamate, P.; Beseme, S.; Murphy, M.; Munir, H.; Daou, A.K.; Dabo, G.; Téguété, I.; et al. Vaccine Confidence During Public Health Challenges and Prior to HPV Vaccine Introduction in Mali. Vaccines 2025, 13, 535. https://doi.org/10.3390/vaccines13050535
Crippin T, Tounkara K, Diarra I, Kamate P, Beseme S, Murphy M, Munir H, Daou AK, Dabo G, Téguété I, et al. Vaccine Confidence During Public Health Challenges and Prior to HPV Vaccine Introduction in Mali. Vaccines. 2025; 13(5):535. https://doi.org/10.3390/vaccines13050535
Chicago/Turabian StyleCrippin, Tiffani, Karamoko Tounkara, Ibrahima Diarra, Pierre Kamate, Sarah Beseme, Matthew Murphy, Hayley Munir, Amalle Keita Daou, Garan Dabo, Ibrahima Téguété, and et al. 2025. "Vaccine Confidence During Public Health Challenges and Prior to HPV Vaccine Introduction in Mali" Vaccines 13, no. 5: 535. https://doi.org/10.3390/vaccines13050535
APA StyleCrippin, T., Tounkara, K., Diarra, I., Kamate, P., Beseme, S., Murphy, M., Munir, H., Daou, A. K., Dabo, G., Téguété, I., Koita, O., & De Groot, A. S. (2025). Vaccine Confidence During Public Health Challenges and Prior to HPV Vaccine Introduction in Mali. Vaccines, 13(5), 535. https://doi.org/10.3390/vaccines13050535